Sir, Bilateral acute retinal necrosis syndrome following herpes simplex type 1 encephalitis Acute retinal necrosis syndrome (ARN) associated with herpes simplex viral encephalitis has been well described. Bilateral acute retinal necrosis (BARN) in this context is described but is extremely rare. We present a case of BARN following recent herpes simplex type 1 (HSV-1) encephalitis (HSE) in an immune competent patient. 
Correspondence

Case report
A 59-year-old man presented to the ophthalmologist complaining of reduced visual acuity of 6=12 in his left eye. ARN was not recognised until he represented 2 weeks later with further decline in his left eye vision to hand movements and right eye vision reduced to 6/18. On recognition of BARN he was referred to our unit for further management. On arrival, he had bilateral florid, granulomatous uveitis and optic disc swelling. There was widespread bilateral retinal vasculitis and 3601 confluent retinitis. In the left eye, the retinitis extended up to the disc nasally and there was widespread retinal detachment extending to the temporal arcades, Figure 1 .
At 1 month previously, the patient had been admitted with malaise, fever, and speech disturbance. CT imaging showed a low attenuation area in the left temporal lobe, Figure 2 and HSV-1 was detected on polymerase chain reaction (PCR) testing of a cerebrospinal fluid sample. He was treated with intravenous aciclovir 10 mg/kg TDS for 2 weeks and oral corticosteroid.
On admission to our unit, he was restarted on intravenous aciclovir 10 mg/kg TDS. He underwent left eye vitrectomy, 3601 laser retinopexy, and silicone oil tamponade. The right eye also received prophylactic 3601 laser retinopexy. Both eyes received intravitreal foscarnet, 2.4 mg in 0.1 ml. The patient was maintained on intravenous aciclovir for 14 days. Oral prednisolone was introduced after 48 h of intravenous aciclovir for his severe intraocular inflammation. PCR studies of the left vitreous sample were positive for HSV-1 and negative for other herpetic viruses. Lymphocyte surface markers, immunoglobulins and HIV testing were all normal or negative.
The patient was discharged on oral valaciclovir 1 g TDS in addition to a reducing dose of oral steroid. After 2 weeks, the retinal detachment in the left eye recurred in spite of silicone oil tamponade and he also developed a temporal, peripheral retinal detachment in the right eye. At 4 months, the retinal detachments are limited to the anterior edge of the laser barricade and do not extend across the temporal arcades in either eye. His vision is unchanged from discharge at 6/5 right eye, CFs left eye.
We plan to continue valaciclovir for at least 6 months.
Comment
ARN is a rapidly progressive retinal infection caused by herpes viruses. It usually occurs in immunocompetent patients. Although most cases are unilateral, bilateral disease has been reported in up to 35% of patients. 1 This figure is probably determined by early recognition and treatment of first eye involvement. 2 Acute retinal necrosis is a clinical diagnosis and standard diagnostic criteria have been published by Holland et al.
3 VZV and HSV-1 are associated with acute retinal necrosis in the older population while HSV-2 is the more common pathogen in under 25-year olds. 4 We have found 20 cases of unilateral ARN associated with HSE in the absence of human immune deficiency virus in the literature in the last 20 years.
1,4-16 Pepose et al 15 reports a case of HSE 3 weeks following ARN. All others report ARN following HSE with variable time courses (mean of 6=12 years, median 5 years, range 10 days-20 years). BARN following HSE could only be found in seven case reports. [17] [18] [19] [20] [21] [22] The majority of patients in the unilateral ARN group had no other factors which might be associated with impaired host defence. In contrast, the reported cases of BARN following encephalitis all had some associated factors that may have reduced host defence. In two of the seven case reports, the initial encephalitis was either not recognised or there was a significant delay in treatment. 17 Two report association with high-dose intrathecal or pulsed intravenous steroid. 18, 19 One case occurred during iatrogenic immunosuppression with chemotherapy agents 20 and a further case followed craniotomy and oral dexamethasone for a supra sellar lesion. 21 Finally, there was one case of HSV-2 in a neonate. 22 In our case, the only possible compromising factor was administration of dexamethasone over a 6-day period. However, this was given in addition to aciclovir and might be regarded as a standard part of his encephalitis therapy. In this respect, our patient is unique to others reported in the literature with BARN following HSE.
Prompt treatment of HSE is essential as there is a high mortality and morbidity. Early treatment may be important for limiting reactivation or neuronal translocation that could otherwise lead to further virus spread to other CNS sites including the eye. Standard antiviral treatment regimens do not usually extend beyond 14 days. 23 As ARN is potentially blinding with a retinal detachment rate of between 50 and 75%, 24 we question this short-term approach. In general, BARN tends to occur quite soon following encephalitis with most reported within 5 months and only one reported after 42 months. 18 We suggest that oral antiviral agents should be introduced after IV therapy for at least 6 months following HSE to reduce the risk of acute retinal necrosis. Oral valaciclovir, a prodrug of aciclovir has excellent bioavailability and is very well tolerated. 25 Patients with HSV encephalitis should be examined carefully for ocular disease. Patients who have associated factors that may affect host defence should be viewed with a high index of suspicion. Physicians should request immediate specialist review of any patient with HSE developing signs or symptoms of ocular inflammation. Thorough peripheral retinal examination is particularly advised for any patient presenting with uveitis and a previous history of HSE.
